Back to DE D. E. Shaw & Co., Inc.

PBYIPBYI
Showing 8 of 26 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in PUMA BIOTECHNOLOGY INC

D. E. Shaw & Co., Inc. holds 316,343 shares of PBYI (PUMA BIOTECHNOLOGY INC), worth $2.6M as of 2026-Q2. The position was decreased (-9.9% shares). PBYI represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$2.6M

Current Shares

316,343

Total Value Change

+$2.4M

Total Shares Change

+258,955

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
316,343
-9.9%
$2.6M0.0%$8.11
0
2026-Q1
Decreased
351,235
-7.2%
$2.2M0.0%$6.21
0
2025-Q4
Decreased
378,296
-24.1%
$2.3M0.0%$6.01
0
2025-Q3
Decreased
498,598
-22.2%
$2.6M0.0%$5.05
0
2025-Q2
Increased
640,780
+12.1%
$2.2M0.0%$3.33
29
2025-Q1
Increased
571,665
+156.8%
$1.7M0.0%$3.14
41
2024-Q4
Increased
222,608
+287.9%
$678,9540.0%$3.13
40
2024-Q3
New
57,388
-
$146,3390.0%$2.58
31

Other major holders of PBYI: BLACKROCK ADVISORS LLC, FEDERATED HERMES, INC., BNP PARIBAS FINANCIAL MARKETS, FRED ALGER MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used